Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How do insurance plans impact lipitor vs generic cost difference?Can tigecycline overdose worsen infection prognosis?Any restrictions on turkey with lipitor?What year did keytruda receive its first fda approval for cancer use?How quickly does lipitor impact fat absorption?
How does alcohol cause liver damage in the first place? Alcohol is metabolized in the liver into acetaldehyde, a toxic byproduct that directly damages liver cells. This process also produces reactive oxygen species that trigger inflammation and oxidative stress, setting the stage for long-term scarring. What happens to the liver cells during this process? Chronic alcohol use activates hepatic stellate cells, which normally store vitamin A. When activated, these cells turn into myofibroblasts that lay down excessive collagen and other extracellular matrix proteins. The accumulation of this material gradually replaces healthy liver tissue with scar tissue. How long does the process take from drinking to fibrosis? The time course varies widely. Some people develop significant fibrosis after 10–20 years of heavy drinking, while genetic factors, sex, obesity, and coexisting liver diseases such as hepatitis C accelerate the timeline. What role does inflammation play? Persistent inflammation from damaged hepatocytes and activated Kupffer cells releases cytokines that keep stellate cells activated. This andни keep-alive loop maintains the fibrotic process even if drinking stops temporarily. Can stopping drinking reverse fibrosis? Early-stage fibrosis can regress if alcohol is stopped entirely. Once cirrhosis develops, the structural changes are usually irreversible, though stopping drinking improves survival and reduces complications. What treatments are available once fibrosis develops? Current options focus on stopping alcohol use and managing complications. No specific antifibrotic drugs have been approved for alcohol-related liver disease, but clinical trials are testing antifibrotic agents that are already approved for other conditions.
Other Questions About Lead :